Cargando…

Long-term treatment of refractory severe chronic urticaria by omalizumab: analysis of two cases

Detalles Bibliográficos
Autores principales: Fiorino, Irene, Loconte, Filomena, Rucco, Anna Simona, Nico, Andrea, Vacca, Maddalena, Damiani, Elisabetta, Nettis, Eustachio, Caiaffa, Maria Filomena, Macchia, Luigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4221356/
https://www.ncbi.nlm.nih.gov/pubmed/25395932
http://dx.doi.org/10.5114/pdia.2014.44023
_version_ 1782342873179488256
author Fiorino, Irene
Loconte, Filomena
Rucco, Anna Simona
Nico, Andrea
Vacca, Maddalena
Damiani, Elisabetta
Nettis, Eustachio
Caiaffa, Maria Filomena
Macchia, Luigi
author_facet Fiorino, Irene
Loconte, Filomena
Rucco, Anna Simona
Nico, Andrea
Vacca, Maddalena
Damiani, Elisabetta
Nettis, Eustachio
Caiaffa, Maria Filomena
Macchia, Luigi
author_sort Fiorino, Irene
collection PubMed
description
format Online
Article
Text
id pubmed-4221356
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Termedia Publishing House
record_format MEDLINE/PubMed
spelling pubmed-42213562014-11-13 Long-term treatment of refractory severe chronic urticaria by omalizumab: analysis of two cases Fiorino, Irene Loconte, Filomena Rucco, Anna Simona Nico, Andrea Vacca, Maddalena Damiani, Elisabetta Nettis, Eustachio Caiaffa, Maria Filomena Macchia, Luigi Postepy Dermatol Alergol Letter to the Editor Termedia Publishing House 2014-10-22 2014-10 /pmc/articles/PMC4221356/ /pubmed/25395932 http://dx.doi.org/10.5114/pdia.2014.44023 Text en Copyright © 2014 Termedia http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 3.0 Unported License, permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to the Editor
Fiorino, Irene
Loconte, Filomena
Rucco, Anna Simona
Nico, Andrea
Vacca, Maddalena
Damiani, Elisabetta
Nettis, Eustachio
Caiaffa, Maria Filomena
Macchia, Luigi
Long-term treatment of refractory severe chronic urticaria by omalizumab: analysis of two cases
title Long-term treatment of refractory severe chronic urticaria by omalizumab: analysis of two cases
title_full Long-term treatment of refractory severe chronic urticaria by omalizumab: analysis of two cases
title_fullStr Long-term treatment of refractory severe chronic urticaria by omalizumab: analysis of two cases
title_full_unstemmed Long-term treatment of refractory severe chronic urticaria by omalizumab: analysis of two cases
title_short Long-term treatment of refractory severe chronic urticaria by omalizumab: analysis of two cases
title_sort long-term treatment of refractory severe chronic urticaria by omalizumab: analysis of two cases
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4221356/
https://www.ncbi.nlm.nih.gov/pubmed/25395932
http://dx.doi.org/10.5114/pdia.2014.44023
work_keys_str_mv AT fiorinoirene longtermtreatmentofrefractoryseverechronicurticariabyomalizumabanalysisoftwocases
AT locontefilomena longtermtreatmentofrefractoryseverechronicurticariabyomalizumabanalysisoftwocases
AT ruccoannasimona longtermtreatmentofrefractoryseverechronicurticariabyomalizumabanalysisoftwocases
AT nicoandrea longtermtreatmentofrefractoryseverechronicurticariabyomalizumabanalysisoftwocases
AT vaccamaddalena longtermtreatmentofrefractoryseverechronicurticariabyomalizumabanalysisoftwocases
AT damianielisabetta longtermtreatmentofrefractoryseverechronicurticariabyomalizumabanalysisoftwocases
AT nettiseustachio longtermtreatmentofrefractoryseverechronicurticariabyomalizumabanalysisoftwocases
AT caiaffamariafilomena longtermtreatmentofrefractoryseverechronicurticariabyomalizumabanalysisoftwocases
AT macchialuigi longtermtreatmentofrefractoryseverechronicurticariabyomalizumabanalysisoftwocases